-
EP3372225
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3372225
| EP3372225 - NOVEL DOSAGE FORM [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 31.07.2020 Database last updated on 15.05.2024 | |
| Former | Request for examination was made Status updated on 01.03.2019 | ||
| Former | The application has been published Status updated on 10.08.2018 | Most recent event Tooltip | 28.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Develco Pharma Schweiz AG Hohenrainstr. 12D 4133 Pratteln / CH | [2018/37] | Inventor(s) | 01 /
Scheer, Mathias Mozartstrasse 9 79664 Wehr / DE | 02 /
Rey, Helene 7a rue du 6eme RIC 68680 Kembs / FR | [2018/37] | Representative(s) | CH Kilger Anwaltspartnerschaft mbB Fasanenstraße 29 10719 Berlin / DE | [N/P] |
| Former [2018/37] | CH Kilger Anwaltspartnerschaft mbB Fasanenstrasse 29 10719 Berlin / DE | Application number, filing date | 17160206.3 | 09.03.2017 | [2018/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3372225 | Date: | 12.09.2018 | Language: | EN | [2018/37] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 09.08.2017 | Classification | IPC: | A61K9/16 | [2018/37] | CPC: |
A61K9/167 (EP,US);
A61K31/437 (EP);
A61K31/4458 (EP,US);
A61K45/06 (EP);
A61K9/1652 (US);
A61K9/2095 (US)
| C-Set: |
A61K31/437, A61K2300/00 (EP);
A61K31/4458, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/14] |
| Former [2018/37] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | NEUARTIGE DARREICHUNGSFORM | [2018/37] | English: | NOVEL DOSAGE FORM | [2018/37] | French: | NOUVELLE FORME POSOLOGIQUE | [2018/37] | Examination procedure | 28.02.2019 | Amendment by applicant (claims and/or description) | 28.02.2019 | Examination requested [2019/14] | 28.02.2019 | Date on which the examining division has become responsible | 31.07.2020 | Despatch of a communication from the examining division (Time limit: M04) | 25.11.2020 | Reply to a communication from the examining division | 12.10.2022 | Despatch of a communication from the examining division (Time limit: M06) | 18.04.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 29.03.2019 | Renewal fee patent year 03 | 26.02.2020 | Renewal fee patent year 04 | 31.03.2021 | Renewal fee patent year 05 | 31.03.2022 | Renewal fee patent year 06 | 30.03.2023 | Renewal fee patent year 07 | 27.03.2024 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO0035450 (EURO CELTIQUE SA [LU], et al) [Y] 1-15 * example 6A *; | [Y]US6344215 (BETTMAN MARIE J [US], et al) [Y] 1-15 * the whole document *; | [Y]WO2011020032 (KUDCO IRELAND LTD [US], et al) [Y] 1-15* example - *; | [Y] - YANFENG WANG ET AL, "In vitro dissolution andin vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers", BIOPHARMACEUTICS AND DRUG DISPOSITION., US, (20040301), vol. 25, no. 2, doi:10.1002/bdd.390, ISSN 0142-2782, pages 91 - 98, XP055388543 [Y] 1-15 * page 93, paragraph 1 * DOI: http://dx.doi.org/10.1002/bdd.390 | by applicant | WO9903471 |